Case Study

How WCG Statistics Collaborative Helped Breakthrough Therapy Obtain Regulatory Approval

The WCG Statistics Collaborative team became involved in the development process early. WCG Statistics Collaborative helped design the study evaluating the therapy, prepared the final analysis and represented the sponsor in discussions with the FDA. The researchers completed a Phase 1/2 trial and needed biostatistical expertise as they moved into Phase 3. Like most small biotech companies, they didn’t have a large statistical department. Thus, they turned to WCG Statistics Collaborative. 


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Hydrocarbon Online? Subscribe today.

Subscribe to Hydrocarbon Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Hydrocarbon Online